Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
Conditions:   Metastatic Cancer;   Melanoma;   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma;   Colorectal Cancer
Interventions:   Biological: VE800;   Drug: Nivolumab;   Drug: Vancomycin Oral Capsule
Sponsors:   Vedanta Biosciences, Inc.;   Bristol-Myers Squibb (BMS)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 7, 2020 / by / in
Comments